Berkeley Lovelace Jr., NBC News

Berkeley Lovelace Jr.

NBC News

New York, NY, United States

Contact Berkeley

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • NBC News
  • CNBC
  • SCMP News

Recent articles by Berkeley:

Updated Covid boosters cut the infection risk from XBB.1.5 subvariant by nearly half, CDC finds

The report provides the first data on how the updated shots fare against the predominant strain in the U.S. → Read More

People with diabetes struggle to find Ozempic as it soars in popularity as a weight loss aid

Ozempic is the same medication as the popular weight loss drug Wegovy, just at a lower dose. → Read More

A new Alzheimer’s drug will cost $26,500 a year. Who will be able to get it?

A newly approved drug intended to slow the progression of Alzheimer’s disease offers patients hope, but it will come with a steep price tag: $26,500 a year. → Read More

Reports of young children accidentally eating marijuana edibles soar

Edibles are often packaged to look like candy, and children, unaware of the risk, may find them appealing. → Read More

Mark Cuban’s next act on drug costs: Tackling insulin

The billionaire's online drug business is able to offer lower prices by buying medications directly from manufacturers. → Read More

FDA approves 1st drug to delay the onset of Type 1 diabetes

The drug, called Tzield, is the first-ever FDA approved treatment intended to delay the onset of type 1 diabetes in adults and children ages 8 and up. → Read More

FDA opens door to make opioid overdose antidote available over the counter

Over-the-counter versions of naloxone, a lifesaving drug that can reverse opioid overdoses, could begin appearing on pharmacy shelves as early as next year. → Read More

These are the signs and symptoms of flu, RSV and Covid in kids

RSV and other respiratory viruses are spreading in children. RSV symptoms include cough and it can be severe in babies and toddlers. There is no vaccine or treatment. → Read More

FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth

Makena, the only drug approved to prevent premature births, has not shown to be effective and exposes women to “serious risk," the agency's scientists said. → Read More

As Covid cases rise slightly in children, FDA clears omicron booster for kids as young as 5

Children's Covid vaccine targeted to omicron was authorized by the FDA Wednesday. The move comes as cases of omicron in children are increasing slightly. → Read More

FDA approves controversial new drug designed to slow the progress of ALS

The Food and Drug Administration on Thursday approved a new drug to slow the progression of ALS, a fatal neurodegenerative disease for which there is no cure. → Read More

The Inflation Reduction Act aims to lower drug costs — but here’s how Big Pharma could get around it

The Inflation Reduction Act has provisions to lower drug costs, but it's possible that pharma companies could get around them, and keep drug prices high. → Read More

New Covid boosters look a lot like the old ones. Doctors worry that could lead to errors.

Experts are concerned that the updated Covid boosters look too similar to previous versions of the vaccine, and people could receive the wrong dose in error. → Read More

FDA authorizes Pfizer's and Moderna's updated Covid booster shots

The shots target the BA.5 omicron subvariant. The CDC still needs to sign off before shots can be administered. → Read More

New Covid boosters, which target BA.5, haven't yet been tested in people. How well will they work?

The lack of human data means officials likely won’t know how much better the new shots are — if at all — until the fall booster campaign is well underway. → Read More

FDA plans to authorize bivalent boosters by Labor Day, sources say

The new boosters target the BA.5 omicron subvariant. Shots could begin shortly after the Labor Day weekend. → Read More

New Covid boosters expected soon for everyone over 12. Should you wait for another dose?

With updated shots coming soon, should you wait to get another dose or get boosted with the current vaccines now? → Read More

Pfizer just started a late-stage clinical trial of a Lyme disease vaccine

Is there a Lyme disease vaccine? Pfizer started a phase 3 clinical trial of its Lyme disease vaccine. Lyme disease is spreading because of climate change. → Read More

Why is insulin still so expensive for diabetes patients in the U.S.?

Insulin is an essential drug to treat diabetes. Despite existing for over 100 years, 'evergreening,' supply chain issues, and more are keeping insulin costs high. → Read More

FDA advisers to weigh in on updated Covid booster shots for the fall

The FDA has said scientists need to determine what sorts of updates the shots would require by the end of June. → Read More